Last updated on February 2018

Short Duration Treatment of Non-severe Community Acquired Pneumonia


Brief description of study

To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).

Clinical Study Identifier: NCT01963442

Contact Investigators or Research Sites near you

Start Over

Anne-Claude CREMIEUX, PH

CH d'Annecy Genevois
Metz-Tessy, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.